CN
News & Events

News & Events

Chipscreen Highlights: Stay Updated on Recent Hot Topics

Select year

2026 2025 2024 2023 2022 Earlier
shown/page
5
5 10 15 20

2026.04.23

2026 ASCO丨Multiple innovative Drug Studies from Chipscreen Biosciences Selected
2026 ASCO丨Multiple innovative Drug Studies from Chipscreen Biosciences Selected

Full text

2026.04.23

Published in JAMA ! Chidamide DEB Study Reshapes the First-Line Treatment Landscape for DE-DLBCL
Published in JAMA ! Chidamide DEB Study Reshapes the First-Line Treatment Landscape for DE-DLBCL

Full text

2026.04.18

AACR 2026 | Dual Breakthroughs in Novel Target ADCs and Small Molecules: Four Original Oncology Pipeline Studies from Chipscreen and Chipscreen Newway Biosciences Accepted for Presentation
AACR 2026 | Dual Breakthroughs in Novel Target ADCs and Small Molecules: Four Original Oncology Pipeline Studies from Chipscreen and Chipscreen Newway Biosciences Accepted for Presentation

Full text

2026.03.16

First-in-Class Combination Therapy: Clinical Trial Application for Chiglitazar Sodium/Metformin Extended-Release Tablets for Type 2 Diabetes Approved
First-in-Class Combination Therapy: Clinical Trial Application for Chiglitazar Sodium/Metformin Extended-Release Tablets for Type 2 Diabetes Approved

Full text

2026.03.16

Chipscreen Biosciences Receives NMPA Approval for IND of Novel PRMT5 Inhibitor CS08399 for MTAP-Deficient Tumors
Chipscreen Biosciences Receives NMPA Approval for IND of Novel PRMT5 Inhibitor CS08399 for MTAP-Deficient Tumors

Full text
Media contact

Media contact

  • Media contact

    （+86）0755-36993500

  • Media contact

    pr@juliucq.com